IDEX Q3 sales beat on increased volumes

By Reuters News


Overview

  • U.S. engineered products maker's Q3 sales rose 8% yr/yr, beating analyst expectations

  • Adjusted EPS for Q3 increased 15%, beating analyst expectations

  • Company raised full-year guidance for organic sales and adjusted EPS


Outlook

  • IDEX raises full-year organic sales growth outlook to 6.5%-6.8% from 5%-6%

  • Company now expects full-year adjusted diluted EPS of $8.91-$8.96, up from $8.70-$8.85

  • Company cites improved visibility and momentum as reasons for raising full-year guidance


Result Drivers

  • HIGHER VOLUMES AND PRICING - Co said Q3 sales growth was driven by increased volumes, especially in Health & Science Technologies, and positive pricing across segments

  • MARGIN EXPANSION - Co attributed higher gross margin to volume leverage, productivity improvements and favorable mix, partly offset by price/cost headwinds

  • AI AND DATA CENTER DEMAND - Co said AI-driven demand for data center power and semiconductor markets boosted Health & Science Technologies segment volumes


Company press release:


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q3 Sales

Beat

$951.70 mln

$930.75 mln (12 Analysts)

Q3 Adjusted EPS

Beat

$2.33

$2.23 (12 Analysts)

Q3 EPS

$1.95

Q3 Adjusted Net Income

Beat

$172.80 mln

$155.34 mln (7 Analysts)

Q3 Adjusted EBITDA

Beat

$264.80 mln

$231.20 mln (2 Analysts)

Q3 Adjusted Gross Margin

45.20%


Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 11 "strong buy" or "buy", 5 "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the industrial machinery & equipment peer group is "buy"

  • Wall Street's median 12-month price target for IDEX Corporation is $267.00, about 14.5% above its October 27 closing price of $233.21

  • The stock recently traded at 25 times the next 12-month earnings vs. a P/E of 26 three months ago


Reuters Recommended Reads

  • Oct 27 - Engineered components maker Crane's Q3 sales beat, partly on acquisitions

  • Oct 27 - Illinois Tool Works Inc beats Q3 EPS estimates, raises 2026 outlook

  • Oct 27 - Mirion Technologies Q3 revenue beats estimates, lifts 2026 outlook


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.
The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.
To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.
 

Cryptocurrency-related content is intended solely as news and market commentary. Crypto Derivatives are not available to Retail clients registered with Capital Com (UK) Ltd.